
Loading, please wait...

Loading, please wait...

A significant longitudinal study recently examined the child screen time impact on future cognitive and academic outcomes. Researchers followed the GUSTO birth cohort in Singapore from age 1 to 8 years to track digital consumption habits. Consequently, they discovered that high screen exposure during early developmental windows leads to lasting negative effects on school-age success.
Specifically, children with higher screen viewing time at ages 1, 1.5, and 6 years demonstrated poorer academic scores by age 9. Furthermore, the analysis linked screen time at age 1 and 6 with reduced working memory at age 10.5. These findings suggest that infancy and the transition to primary school represent critical periods for brain development. During these times, the brain requires active stimulation rather than passive viewing.
Moreover, while cumulative screen time across childhood consistently predicted lower academic performance, it did not show a similarly strong link with working memory. This finding indicates that the earliest exposures during infancy might be the most detrimental to cognitive functions. However, physicians must still advise parents to limit recreational screen use throughout middle childhood. Active engagement and physical play remain the gold standard for healthy neurodevelopment.
In India, the Indian Academy of Pediatrics (IAP) provides clear guidelines to manage this concern. They recommend zero screen time for children under 2 years. Additionally, children aged 2 to 5 should not exceed one hour of high-quality, supervised content daily. By following these evidence-based limits, families can successfully reduce the long-term child screen time impact on cognitive health and academic readiness.
Higher screen viewing time during infancy and early childhood links to lower scores in standardized achievement tests. This occurs because digital consumption often displaces essential social interactions and active developmental play.
Research suggests that screen exposure at age 1 has the strongest negative association with later academic and memory outcomes. Protecting the brain during this sensitive developmental window is crucial for long-term cognitive health.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A longitudinal study reveals that screen viewing time at ages 1, 1.5, and 6 years correlates with lower academic performance and poorer working memory later...
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today